ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-1.09%
US Tech 100
20,778.00
-0.69%
S&P 500
6,040.53
-0.50%
US Dollar vs CAD
1.45405
0.00%
Bitcoin
102,027.86
-0.38%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Serina Therapeutics Inc (SER)

  7. Serina Therapeutics Inc (SER) News

SER

Serina Therapeutics (SER)

Serina Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:SER
DateTimeSourceHeadlineSymbolCompany
01/15/20253:05PMGlobeNewswire Inc.Serina Therapeutics Announces Sale of UniverXome SubsidiaryAMEX:SERSerina Therapeutics Inc
01/14/20254:25PMGlobeNewswire Inc.Serina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
01/06/20253:07PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
12/18/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
12/16/20245:00AMGlobeNewswire Inc.Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024AMEX:SERSerina Therapeutics Inc
12/11/20245:05AMGlobeNewswire Inc.Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitAMEX:SERSerina Therapeutics Inc
12/09/20243:45PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:SERSerina Therapeutics Inc
12/02/20244:22PMGlobeNewswire Inc.Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
12/02/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
11/22/20243:15PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SERSerina Therapeutics Inc
11/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
11/12/20244:00PMGlobeNewswire Inc.Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
11/12/20243:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SERSerina Therapeutics Inc
11/11/20244:40PMGlobeNewswire Inc.Serina Therapeutics Makes Grants to New Employees Under Inducement PlanAMEX:SERSerina Therapeutics Inc
11/06/20243:45PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:SERSerina Therapeutics Inc
11/06/20243:31PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:SERSerina Therapeutics Inc
11/06/20245:32AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SERSerina Therapeutics Inc
11/01/20248:15AMEdgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsAMEX:SERSerina Therapeutics Inc
10/02/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
10/02/20247:30AMGlobeNewswire Inc.Serina Therapeutics to Present at the 14th Annual Injectables SummitAMEX:SERSerina Therapeutics Inc
09/16/20245:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
09/12/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
09/04/20245:42PMGlobeNewswire Inc.Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:SERSerina Therapeutics Inc
08/23/20244:21PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:SERSerina Therapeutics Inc
08/19/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
08/09/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
08/09/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SERSerina Therapeutics Inc
08/09/20243:15PMGlobeNewswire Inc.Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
07/29/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
07/29/20247:30AMGlobeNewswire Inc.Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics SummitAMEX:SERSerina Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:SER

Your Recent History

USOTC
IQST
iQSTEL (QX)
USOTC
UMAV
UAV Corpoation (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
HMBL
HUMBL (PK)
AMEX
SPY
SPDR S&P 500
USOTC
PSRU
Valiant Eagle (PK)
USOTC
AFFU
Affluence (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
DPLS
DarkPulse (PK)
USOTC
MGON
Megola (PK)
USOTC
RDAR
Raadr (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
GTCH
GBT Technologies (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads